Abstract
Research question: How many patients in Denmark were treated with fertility-sparing surgery (FSS) for epithelial ovarian cancer (EOC) and what was their prognosis compared with patients treated with radical surgery (RS)? Design: This study was a retrospective Danish nationwide study, evaluating the effect of FSS compared with RS in patients with EOC, age ≤45 years and International Federation of Gynecology and Obstetrics (FIGO) stage ≤IC3 from 2005 to 2016. Results: A total of 106 patients were included. Of these, 13 were treated with FSS and 93 were treated with RS. Median age was 27 versus 42 years (P < 0.0001). Overall survival did not differ significantly between the two groups. Overall survival rate in the FSS group was 100%, while the overall survival in the RS group was 87%. Disease-specific survival was 100% in the FSS group and 91% in the RS group. Conclusions: This study shows that patients treated with FSS for FIGO stage I EOC do not have an impaired survival compared with patients treated with RS. Nevertheless, the conclusion must be interpreted with caution due to the limited number of patients and the retrospective nature of the study. Larger studies are needed before conclusions can be drawn.
| Original language | English |
|---|---|
| Journal | Reproductive BioMedicine Online |
| Volume | 37 |
| Issue number | 1 |
| Pages (from-to) | 71-76 |
| ISSN | 1472-6483 |
| DOIs | |
| Publication status | Published - Jul 2018 |
Keywords
- Adolescent
- Adult
- Denmark
- Disease-Free Survival
- Female
- Fertility Preservation/methods
- Humans
- Middle Aged
- Neoplasms, Glandular and Epithelial/mortality
- Organ Sparing Treatments/methods
- Ovarian Neoplasms/mortality
- Prognosis
- Retrospective Studies
- Survival Rate
- Treatment Outcome
- Young Adult
